Nektar Therapeutics (NKTR) Tax Rate Growth (3y) (2013 - 2026)

Nektar Therapeutics (NKTR) Tax Rate Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Nektar Therapeutics 1.76 Bn 1.19 Bn 3.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.00
Dec 31, 2025 -3,679.00
Sep 30, 2025 -17.00
Jun 30, 2025 54.00
Mar 31, 2025 3.00
Dec 31, 2024 -35,778.00
Sep 30, 2024 6.00
Jun 30, 2024 20.00
Mar 31, 2024 17.00
Dec 31, 2023 18.00
Sep 30, 2023 15.00
Jun 30, 2023 27.00
Mar 31, 2023 19.00
Dec 31, 2022 13,593.00
Sep 30, 2022 36.00
Jun 30, 2022 3.00
Mar 31, 2022 -2.00
Dec 31, 2021 -184.00
Sep 30, 2021 -101.00
Jun 30, 2021 -68.00